Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation

University of Chicago · NCT06317701

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
30
US sites recruiting
1
Study start
April 4, 2024
Record last updated
January 28, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to determine if the treatment of Obstructive sleep apnea (OSA) by hypoglossal nerve stimulation (HGNS) will alter glucose metabolism. The study team will also determine if the treatment of Obstructive sleep apnea (OSA) by (hypoglossal nerve stimulation) HGNS will alter predictors of cardiovascular outcomes.

Being studied: Hypoglossal Nerve Stimulation (HGNS)

Conditions: Obstructive Sleep Apnea

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Overweight or obese males and females BMI 25 kg/m2 to 40 kg/m2
  • Age 18 years and older
  • Diagnosed with obstructive sleep apnea by Apnea-Hypopnea Index >15 events/hr using 4% oxygen desaturation criteria and \< 25% central events/hr on prior sleep testing Data can be derived from home sleep testing or in-lab polysomnogram
  • Not able to use positive airway pressure >4 hours for 5 nights/week or unwilling to use positive airway pressure

Exclusion Criteria

  • Insulin-dependent Diabetes
  • Inability to undergo in-lab polysomnography or home sleep testing
  • Central Nervous System (CNS) disease with impairment of cognitive function (dementia) and/or muscle paresis, such as stroke
  • Currently pregnant, trying to get pregnant or nursing
  • age \< 18 years
  • Regular and adherent CPAP use per clinical guidelines
  • Current night shift or rotating shift work
  • Diagnosis of another sleep disorder (e.g. periodic limb movement disorder)
  • Current systemic steroid use
  • Predominantly central sleep apnea or requiring oxygen or bi-level positive airway pressure or advanced positive airway pressure modalities
  • Protected patient: under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision, including hospitalized without consent

Recruiting US locations

  • The University of Chicago

    Chicago, IL 60637

    Site contact: Phillip LoSavio, MD, MS · 773-702-5189 · Phillip.Losavio@bsd.uchicago.edu

Study contacts (from the official record)

  • Phillip LoSavio, MD, MS · 773-702-5189 · Phillip.Losavio@bsd.uchicago.edu
  • Carlisa Dixon · 773-834-4337 · cdixon520@bsd.uchicago.edu
All sleep studies in Illinois →
Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth… (NCT06317701) | Bored Studies